Cyclothiazomycin B1
| Internal ID | ffbf065f-ad9b-4016-88df-8807edc8edc2 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | (12S,27S,30R,36S,42Z,48S,51S,55S,62Z)-55-(2-amino-2-oxoethyl)-36-(3-carbamimidamidopropyl)-42,62-di(ethylidene)-33,51-dimethyl-15-methylidene-13,28,34,37,40,43,49,53,60,63-decaoxo-6,10,17,21,25,32,57-heptathia-14,29,35,38,41,44,50,54,61,64,65,66,67,68,69,70,71-heptadecazadecacyclo[31.19.12.14,52.15,8.19,12.116,19.120,23.124,27.156,59.044,48]henheptaconta-1(52),2,4(66),5(71),7,9(70),16(69),18,20(68),22,24(67),56(65)-dodecaene-30-carboxylic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C61H69N21O13S7/c1-6-28-49(90)81-61(5)59(95)80-30(10-8-14-65-60(63)64)45(86)66-17-42(84)69-29(7-2)57(92)82-15-9-11-40(82)50(91)67-25(3)43-27(44(85)72-32(16-41(62)83)53-74-34(19-97-53)47(88)71-28)12-13-31(70-43)52-78-37(22-100-52)54-75-33(18-98-54)46(87)68-26(4)51-77-36(21-96-51)56-79-38(23-101-56)55-76-35(20-99-55)48(89)73-39(24-102-61)58(93)94/h6-7,12-13,21-23,25,30,32-35,39-40H,4,8-11,14-20,24H2,1-3,5H3,(H2,62,83)(H,66,86)(H,67,91)(H,68,87)(H,69,84)(H,71,88)(H,72,85)(H,73,89)(H,80,95)(H,81,90)(H,93,94)(H4,63,64,65)/b28-6-,29-7-/t25-,30-,32-,33+,34?,35+,39-,40-,61?/m0/s1 |
| InChI Key | GMFKDKZZMAPRGJ-GLERVACHSA-N |
| Popularity | 3 references in papers |
| Molecular Formula | C61H69N21O13S7 |
| Molecular Weight | 1528.80 g/mol |
| Exact Mass | 1527.3428696 g/mol |
| Topological Polar Surface Area (TPSA) | 699.00 Ų |
| XlogP | -0.30 |
| Atomic LogP (AlogP) | 0.02 |
| H-Bond Acceptor | 27 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 7 |
| RefChem:130013 |
| (12S,27S,30R,36S,42Z,48S,51S,55S,62Z)-36-(3-carbamimidamidopropyl)-42,62-di(ethylidene)-13,28,34,37,40,49,53,60,63-nonahydroxy-55-(2-hydroxy-2-iminoethyl)-33,51-dimethyl-15-methylidene-43-oxo-6,10,17,21,25,32,57-heptathia-14,29,35,38,41,44,50,54,61,64,65,66,67,68,69,70,71-heptadecazadecacyclo(31.19.12.14,52.15,8.19,12.116,19.120,23.124,27.156,59.044,48)henheptaconta-1(52),2,4(66),5(71),7,9(70),13,16(69),18,20(68),22,24(67),28,34,37,40,49,53,56(65),60,63-henicosaene-30-carboxylic acid |
| (12S,27S,30R,36S,42Z,48S,51S,55S,62Z)-55-(2-amino-2-oxoethyl)-36-(3-carbamimidamidopropyl)-42,62-di(ethylidene)-33,51-dimethyl-15-methylidene-13,28,34,37,40,43,49,53,60,63-decaoxo-6,10,17,21,25,32,57-heptathia-14,29,35,38,41,44,50,54,61,64,65,66,67,68,69,70,71-heptadecazadecacyclo(31.19.12.14,52.15,8.19,12.116,19.120,23.124,27.156,59.044,48)henheptaconta-1(52),2,4(66),5(71),7,9(70),16(69),18,20(68),22,24(67),56(65)-dodecaene-30-carboxylic acid |
| CHEMBL1819626 |
| CHEBI:211166 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.6446 | 64.46% |
| Caco-2 | - | 0.8627 | 86.27% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | - | 0.5857 | 58.57% |
| Subcellular localzation | Mitochondria | 0.5939 | 59.39% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8034 | 80.34% |
| OATP1B3 inhibitior | + | 0.9328 | 93.28% |
| MATE1 inhibitior | - | 0.7600 | 76.00% |
| OCT2 inhibitior | - | 0.7250 | 72.50% |
| BSEP inhibitior | + | 0.9718 | 97.18% |
| P-glycoprotein inhibitior | + | 0.7423 | 74.23% |
| P-glycoprotein substrate | + | 0.8821 | 88.21% |
| CYP3A4 substrate | + | 0.7544 | 75.44% |
| CYP2C9 substrate | - | 0.6129 | 61.29% |
| CYP2D6 substrate | - | 0.8724 | 87.24% |
| CYP3A4 inhibition | - | 0.9128 | 91.28% |
| CYP2C9 inhibition | - | 0.7811 | 78.11% |
| CYP2C19 inhibition | - | 0.7611 | 76.11% |
| CYP2D6 inhibition | - | 0.9048 | 90.48% |
| CYP1A2 inhibition | - | 0.7593 | 75.93% |
| CYP2C8 inhibition | + | 0.8642 | 86.42% |
| CYP inhibitory promiscuity | - | 0.9536 | 95.36% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.9200 | 92.00% |
| Carcinogenicity (trinary) | Non-required | 0.5686 | 56.86% |
| Eye corrosion | - | 0.9822 | 98.22% |
| Eye irritation | - | 0.8957 | 89.57% |
| Skin irritation | - | 0.7539 | 75.39% |
| Skin corrosion | - | 0.9171 | 91.71% |
| Ames mutagenesis | + | 0.5400 | 54.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7094 | 70.94% |
| Micronuclear | + | 0.8900 | 89.00% |
| Hepatotoxicity | - | 0.6289 | 62.89% |
| skin sensitisation | - | 0.8225 | 82.25% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.9250 | 92.50% |
| Nephrotoxicity | - | 0.8846 | 88.46% |
| Acute Oral Toxicity (c) | III | 0.5517 | 55.17% |
| Estrogen receptor binding | - | 0.5231 | 52.31% |
| Androgen receptor binding | + | 0.7761 | 77.61% |
| Thyroid receptor binding | + | 0.7716 | 77.16% |
| Glucocorticoid receptor binding | + | 0.8111 | 81.11% |
| Aromatase binding | + | 0.7996 | 79.96% |
| PPAR gamma | + | 0.7708 | 77.08% |
| Honey bee toxicity | - | 0.6239 | 62.39% |
| Biodegradation | - | 0.9000 | 90.00% |
| Crustacea aquatic toxicity | - | 0.6000 | 60.00% |
| Fish aquatic toxicity | + | 0.9536 | 95.36% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.00% | 96.09% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 98.83% | 93.03% |
| CHEMBL2581 | P07339 | Cathepsin D | 98.69% | 98.95% |
| CHEMBL1628481 | P35414 | Apelin receptor | 98.17% | 97.89% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 98.09% | 83.82% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 98.00% | 92.97% |
| CHEMBL2093869 | P05106 | Integrin alpha-IIb/beta-3 | 97.84% | 95.42% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.83% | 91.11% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 97.18% | 93.00% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 96.92% | 90.17% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 95.21% | 86.33% |
| CHEMBL3012 | Q13946 | Phosphodiesterase 7A | 95.21% | 99.29% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 94.95% | 99.23% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 94.56% | 94.45% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.21% | 90.71% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 93.90% | 94.75% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 93.59% | 85.00% |
| CHEMBL2243 | O00519 | Anandamide amidohydrolase | 93.44% | 97.53% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 93.29% | 80.71% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 93.25% | 95.56% |
| CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 93.12% | 95.69% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 92.99% | 90.08% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 92.34% | 95.89% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 91.75% | 96.90% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 90.29% | 97.64% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 89.49% | 96.33% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 88.94% | 91.24% |
| CHEMBL241 | Q14432 | Phosphodiesterase 3A | 88.50% | 92.94% |
| CHEMBL4506 | Q96EB6 | NAD-dependent deacetylase sirtuin 1 | 87.79% | 88.33% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 86.96% | 94.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 86.68% | 97.09% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 86.61% | 91.03% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 86.32% | 95.83% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 85.83% | 98.33% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 84.97% | 85.14% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 83.51% | 82.38% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 82.78% | 91.19% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 82.59% | 95.93% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 81.74% | 95.56% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 81.62% | 100.00% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 81.34% | 95.00% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 80.47% | 100.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 80.38% | 95.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 56682060 |
| LOTUS | LTS0202790 |
| wikiData | Q77492964 |